Even isoflurane
1991; Lippincott Williams & Wilkins; Volume: 13; Issue: 6 Linguagem: Inglês
10.1002/hep.1840130634
ISSN1527-3350
Autores Tópico(s)Electrolyte and hormonal disorders
ResumoHepatologyVolume 13, Issue 6 p. 1251-1253 EditorialFree Access Even isoflurane Hyman Zimmerman M.D., Hyman Zimmerman M.D. Armed Forces Institute of Pathology, Washington, D.C. 20306–6000Search for more papers by this author Hyman Zimmerman M.D., Hyman Zimmerman M.D. Armed Forces Institute of Pathology, Washington, D.C. 20306–6000Search for more papers by this author First published: June 1991 https://doi.org/10.1002/hep.1840130634Citations: 22AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat References 1 Brunt EM, White H, Marsh JW, Holtmann B, Peters MB. Fulminant hepatic failure after repeated exposure to isoflurane anesthesia: a case report. HEPATOLOGY 1991; 13: 1017– 1021. 2 Gregoire B, Smiley RK. Acute hepatitis in a patient with mild factor IX deficiency after anesthesia with isoflurane. Can Med Assoc J 1986; 135: 645– 646. 3 Carrigan TV, Straugn WJ. A report of hepatic necrosis and death following isoflurane anesthesia. Anesthesiology 1987; 67: 581– 583. 4 Stoelting EK, Blitt CD, Cohen FJ, Merin RG. Hepatic dysfunction after isoflurane anesthesia. Anesth Analg 1987; 66: 147– 153. 5 Zimmerman HJ. Anesthetic agents. In: HJ Zimmerman, ed. Hepatotoxicity: adverse effects of drugs and other chemicals on the liver. New York: Appleton-Century-Crofts, 1978: 370– 394. 6 Eger EI, Smuckler EA, Farrell LD, Goldsmith CE, Johnson BH. Is enflurane hepatotoxic? Anesth Analg 1986; 65: 21– 30. 7 Koff RG. Postoperative jaundice. Surg Clin North Am 1975; 59: 823– 837. 8 Slater EM, Gibson JM, Dykes MHM, Walzer SG. Postoperative hepatic necrosis: its incidence and diagnostic value in association with administration of halothane. N Engl J Med 1964; 270: 983– 987. 9 Dykes MHM. Halothane and the liver: a review of the immunologic and metabolic aspect of the relationship. Can J Surg 1972; 15: 217– 238. 10 Simpson BR, Strunin L, Walton L. Halothane hepatitis: fact or fancy. Proc R Soc Med 1973; 66: 2– 8. 11 Combes B. Halothane-induced liver damages: an entity. N Engl J Med 1969; 280: 558– 559. 12 Sherlock S. Halothane hepatitis: progress. Gut 1971; 12: 324– 37. 13 Simpson BR, Strunin L, Walton B. Evidence for halothane hepatotoxicity is equivocal. In: FJ Ingelfinger, AS Relman, M Finland, eds. Controversy in internal medicine. Philadelphia: W.B. Saunders Co., 1974: 580– 595. 14 Defalque FJ. The first delayed chloroform poisoning. Anesth Analg 1968; 47: 374– 375. 15 Adriani J, Yarbrough WM. Drugs containing halogen atoms: toxicity and lack of toxicity. J Med Assoc Ga 1972; 61: 347. 16 Little DM. Effects of halothane on liver function. In: NM Green. ed. Clinical anesthesia. Philadelphia: F.A. David, 1968: 85– 137. 17 Johnson M. Halothane: the first five years. Anesthesiology 1961; 22: 591– 614. 18 Sadove MS, Wallace VE. Halothane. Philadelphia: F.A. Davis, 1962. 19 Cousins MJ, Plummer JL, Hall P. Toxicity of volatile anesthetic agents. Can Anaesth 1985; 32: 552– 560. 20 Brown BR, Gandolfi AJ. Adverse effects of volatile anaesthetic. Br J Anaesth 1987; 59: 14– 23. 21 Lunam CA, Cousins MJ, Hall P. Guinea pig model of halothane hepatotoxicity in the absence of enzyme induction and hypoxia. J Pharmacol Exp Ther 1985; 232: 802– 813. 22 Lewis JH, Zimmerman HJ, Ishak KG, Mulluk FG. Enflurane hepatotoxicity: a clinicopathologic study of 24 cases. Ann Intern Med 1983; 98: 984– 992. 23 Berman AL, Kuhnert L, Phythyn JM, Holiday DA. Isoflurane and enflurane-induced hepatic necrosis in triidothyronine pretreated rats. J Averthesive 1983; 58: 1– 5. 24 Recknagel RO, Glenn EA Jr. Carbon tetrachloride hepatotoxicity: an example of lethal cleavage. Crit Rev Toxicol 1973; 2: 263– 297. 25 Satch H, Gillette JR, Takemura T, Ferrans VJ, Jelenich SE, Kenna JG, Neuberger J, et al. Investigation of the immunological basis of halothane-induced hepatotoxicity. Adv Exp Med Biol 1986; 197: 657– 673. 26 Neuberger J, Kenna JG. Halothane hepatitis: a model of immunemediated drug hepatotoxicity. Clin Sci 1987; 72: 263– 271. 27 Benjamin SB, Goodman ZD, Ishak KG, Zimmerman HJ. The morphologic spectrum of halothane-induced hepatic injury: analysis of 77 cases. Hepatotoxicity 1985; 5: 1163– 1171. 28 Gelman S. Halothane hepatotoxicity again? Anesth Analg 1986; 65: 831– 834. 29 Tagaki T, Islia H, Takahaski H, Kato S, Okuno F, Ebihara Y, Yamauchi H, et al. Potentiation of halothane hepatotoxicity by chronic ethanol administration in rat: an animal model of halothane hepatitis. Pharmacol Biochem Behav 1983; 18 (Suppl 1): 461– 465. 30 Jones RM, Koblen DD, Cashman JN, Eger ET II. Biotransformation and hepatorenal function in volunteers after exposure to desflorane. Br J Anaesth 1990; 64: 482– 487. Citing Literature Volume13, Issue6June 1991Pages 1251-1253 ReferencesRelatedInformation
Referência(s)